from Yahoo Finance https://ift.tt/2X89X3h
-
Hedge Funds Have Never Been This Bullish On The Sherwin-Williams (SHW)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
from Yahoo Finance https://ift.tt/2M1KPF5
-
Novartis inks deal to make Mass General Brigham’s COVID-19 vaccine candidate
Novartis’s gene therapy unit AveXis has signed a manufacturing deal to help produce a novel genetic COVID-19 vaccine candidate being developed by U.S. researchers in Massachusetts, a spokeswoman for the Swiss drugmaker confirmed on Thursday. Massachusetts General Hospital and Massachusetts Eye and Ear are developing a vaccine candidate that relies on adeno-associated viral (AAV) vector technology to produce immunity. AveXis, which makes Novartis’s $2.1 million-per-patient gene therapy Zolgensma for the hereditary disease spinal muscular atrophy, is contributing technology, expertise and its manufacturing supply chain at no cost, it said.
from Yahoo Finance https://ift.tt/3c9myYb
The Latest
-
3 of the best ASX 200 shares to buy and hold for 10 years
-
The new age of Monetary Policy: an in-depth analysis of Federal Reserve Policy in the 2008 and 2020 financial crises
-
Media coverage of rally
-
2 safe ASX dividend shares for income investors to buy right now